Note: This company is no longer actively listed. Financial data shown is historical.
Key market metrics for Dishman Pharmaceuticals & Chemicals (DISHMAN) listed on NSE. For pharmaceuticals sector companies, these metrics provide a snapshot of Dishman Pharmaceuticals & Chemicals 's market valuation and enterprise value, essential for comparing against intrinsic value estimates.
We analyze Dishman Pharmaceuticals & Chemicals using multiple valuation models appropriate for PHARMACEUTICALS companies. For PHARMACEUTICALS companies, we use P/E Ratio Analysis, Discounted Cash Flow (DCF), and EPS Growth Valuation to determine fair value estimates for Dishman Pharmaceuticals & Chemicals stock.
10-year Price-to-Earnings ratio trend
The P/E ratio measures how much investors pay for each rupee of earnings (Share Price / EPS). A higher PE suggests the market expects strong future growth, while a lower PE may indicate undervaluation or slower growth prospects. Compare Dishman Pharmaceuticals & Chemicals 's current PE against its historical median and PHARMACEUTICALS peers to gauge whether the stock is trading at a premium or discount relative to its earnings.
Go beyond charts — get fair value estimates from multiple valuation models and detailed assessment breakdowns.
Just ₹833/month
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: FY 2018